RULES AND LAWS IN MEDICAL PRACTICE: PART 2
Michael R. Lowe, Esq, Board Certified Health Law Attorney, Longwood, FL; Marvin C. Mengel, MD, JD, Clinical
Associate Professor of Medicine, University of Florida College of Medicine, Gainesville, and Medical Director of
Community Hospitals, Orlando Health, Orlando, FL
Educational Objectives
| The goal of this program is to aid the physician in complying with some of the legal considerations and regulations applying
to the off-label use of drugs and medical devices, the provision of services through medical spas and retail medical clinics,
and physician-hospital transactions. After hearing and assimilating this program, the clinician will be better able to:
|
 | 1. Cite the reasons for the increase in medical spas and retail medicine clinics.
|
 | 2. Describe some of the rules pertaining to licensure and proper supervision of physician extenders; medical records
and privacy; the treatment of Medicare patients and the use of advance beneficiary notices (ABNs).
|
 | 3. Explain the regulatory and legal consequences of the improper off-label use of drugs, medications, and medical devices.
|
 | 4. Describe key considerations when selling a physician practice, or entering physician employment, physician recruitment,
medical director, call coverage, joint venture, or gainsharing agreements.
|
 | 5. Avoid violations of the Stark Law and federal antikickback statute.
|
Faculty Disclosure
In adherence to ACCME Standards for Commercial Support, Audio-Digest requires all faculty and members of the planning
committee to disclose relevant financial relationships within the past 12 months that might create any personal conflicts
of interest. Any identified conflicts were resolved to ensure that this educational activity promotes quality in health
care and not a proprietary business or commercial interest. For this program, the faculty and planning committee reported
nothing to disclose.
Acknowledgement
Mr. Lowe and Dr. Mengel were recorded at the 30th Annual Internal Medicine Conference: Back to the Patient!, held
July 14-18, 2008, in Orlando, FL and sponsored by Orlando Health. The Audio-Digest Foundation thanks Mr. Lowe,
Dr. Mengel and Orlando Health for their cooperation in the production of this program.
Off-label Use of Drugs and Other Legal Traps
| Introductory remarks: estimated shortage of 400,000 physicians in United States by year 2014; recent Gallup poll
found health care professionals most trusted people in United States; 70,000,000 baby boomers enter Medicare in next 20
yr, with more discretionary income than ever before; predicted they will spend ≤50% on health, wellness, and beauty at
medical spas and retail medicine clinics; services offered by medical spas include weight loss, diet and nutritional counseling,
antiaging modalities, and laser procedures, eg, hair removal; different from traditional office visit and prescription
of medications; patient attitudes becoming increasingly suspicious of medications; looking for alternative methods of
health care; want advice from health care professionals on new modalities; off-label use of drugs or servicesno clear
set of laws and rules regulating this
|
| Health care professional who can perform services and procedures: physicians should check with their state
Licensing Boards or Department of Health about licensing and supervision requirements; speaker offers examples of
Florida licensing regulations and supervision requirements for nutritional counseling and laser procedures; know laws
and understand how to use them to your advantage; ancillary professionals and providers useful under proper supervision;
use physician extenders, but understand what they can and cannot be allowed to do
|
| Legal considerations: licensure and supervision of providers nurse practitioners (NPs) and physician assistants
(PAs) must be individually licensed in state in which they practice; know your states supervision requirements; medical
records and privacykeeping careful records essential, especially if using drugs off label (keep record of dosages;
speaker recommends keeping manufacturers label and attaching it to records); know state medical practice act considerations,
eg, fee-splitting issues; professional liabilitymake sure insurance carrier covers services being offered; in
Florida, if clinic not owned by hospital, not wholly owned by physicians, or not nonprofit, medical director required if
health care services offered and third party billed (other states have similar statutes; covered by professional liability carriers);
Food and Drug Administration (FDA) off-label use and liability considerationsphysician planning off-label
use of drug or cosmetic procedure must make sure it is covered by insurance carrier; know difference between FDA-approved
and FDA-certified; medical devices must be marketed as certified; only drugs or medications can be advertised
as approved); off-label use permitted by FDA, but physician must research product first (have manufacturer
provide product information, but do not let manufacturer tell you how to market it; every state that licenses physicians
has marketing regulations); Medicare patients and use of advance beneficiary notices (ABNs)ABNs used whenever
Medicare patient seeking noncovered service; if physician planning to provide service not covered by Medicare, ABN required
or patient cannot be charged; use form on Centers for Medicare and Medicaid Services (CMS) Web site; ABN
must be completed before patient sits down with physician; form must state what service will be, that it is not covered,
and what cost will be; must be signed and agreed to, and combined with assignment of benefits or financial responsibility
form; new form required every time patient has noncovered service
|
| Comments: most state medical boards have Web sites where they post their rules and regulations for licensure and supervision;
physicians should review these and consult lawyer only if they do not understand rules; be aware of what FDA says
about off-label use (FDA has off-label use development and approval process); if drug or medication not approved for off-
label use (or if device not certified for off-label use), do not use it for off-label purpose; in Florida, if clinic not properly licensed,
it can be fined, and if Agency for Health Care Administration (AHCA) finds violation, and finds physician working
for clinic, it will report this to Board of Medicine; physician must do homework to ensure facility properly licensed,
and get a written employment agreement (reviewed by legal counsel)
|
| Medical records and privacy: Health Insurance Portability and Accountability Act (HIPAA) complaints have risen
every year since 2003, and number one category of complaints is wrongful disclosure or wrongful use of protected health
information (PHI); physicians working in area of off-label use often working with clinical research company or with its
results; evolving area of liability associated with clinical research; 3 specific types of liabilityfailure to properly
advise and treat patient with respect to clinical research drug, filler, or device; kickbacks, ie, has clinical trial paid
physician to refer patient? privacy lawsuits; check state laws on ownership of medical records; sale of medical data
physicians involved in this must understand legal considerations (HIPAA and state laws) regarding patient privacy;
courts reading into statutes duty to be regulatorily compliant; if signing medical research or clinical trial agreement, make
sure it addresses patient privacy, who is going to use data, and how data to be used (especially if off-label use involved)
|
| Medical malpractice and professional negligence: make sure professional liability insurance policy covers services
you will be offering; most insurance companies not familiar with rules governing off-label use, medical spas, health
and wellness service, weight-loss clinics, and other nontraditional services; physician must advise insurance company
about these issues; when does patient dissatisfaction become professional negligence?in speakers opinion, very
few occasions when patients should be compensated; people equate bad outcomes with negligence, but not necessarily
true; physicians must advise patients up front (eg, give them information sheets on off-label use of drug); document everything
(eg, use of ABN; service performed; any questions patient may have); use physician extenders to speak with patients
(access to physicians number one complaint patients have); speaker suggests that patient dissatisfaction becomes
professional negligence when it is designated as such by a judge and jury; have policy and staff member for handling patients
who demand refund; when issuing a refund, get complete release from patient and discharge him or her in accordance
with applicable state laws; which products and services considered health care services?determined by state
medical boards and CMS; speaker counsels physicians to treat anything they do with patient as health care service
|
| FDA and off-label use: must obtain informed consent from patient (beyond ABN if noncovered service for Medicare
patient); do not do procedure without signed, written consent form (form must advise patient on what he or she is getting
and why, and what potential risks and complications may be); discuss all potential risks with patient and note discussion
in medical records; many manufacturers already have consent forms developed (use their materials); learn about product
so you can use it safely, and educate patient if getting marketing materials from product manufacturer (have them looked
at by counsel to make sure they meet state marketing regulations)
|
| Comments by Dr. Mengel: other area where physician can get into trouble is in performing accepted treatment or test
for unaccepted reason; whether using it for on-label or off-label purpose, to make sure everything documented in
patients chart and procedure followed exactly; if patient uncomfortable with off-label drug or questions, whether he or
she should really be using it, physician should respect this (use really up to patient)
|
| Comments by Mr. Lowe: agrees use up to the patient, but physician should not let patient push him or her into off-label
use; if physician does not think it in patients best interest to use specific modality, device or drug, tell patient, and
document that you told him or her in the record; improper off-label use of drugs can lead to regulatory and disciplinary
actions (example); make sure you know which version of given drug or medication is approved, and what it is approved
for off-label, before using it; with an aging baby boomer population that is more affluent than ever, many Medicare patients
will be seeking the types of services offered at or by medical spas; these services will most likely not be covered;
however, if patients want to use them, use ABN
|
Deal or No Deal: If It Looks Too Good
| Introductory remarks: heavy consolidation starting to occur in health care market because of shortage of physicians;
in last 6 to 12 mo, have seen huge increase in physician-hospital transactions (similar to mid-1990s in volume ,but transactions
different); driving factors for hospitals (eg, physicians leaving hospital medical staffs; loss of revenue to outpatient
facilities); driving factors for physicians (eg, declining reimbursement rates; rapidly rising overhead; malpractice
insurance considerations; bargaining power with third-party payers; desire to lessen administrative burden); percentage
marketing arrangements illegal in Florida, and speaker expects other states to make them illegal also
|
| Types of relationships and transactions: purchase of physician practicesif selling practice, be sure you understand
what it is worth; first step in making deal is having exit strategy; physician employment agreementsmake sure
you understand termination provisions; that you can get back patient medical records and lists; that there is no noncompete
clause (or if there is, that it is minimal); physician recruitment and retention agreementshospitals and other
healthcare institutions are legally able to recruit physicians to medically underserved areas; federal regulatory considerations
(specific requirements to make agreements compliant with Stark Law and federal anti-kickback statute; if physician
recruited by existing practice, federal government strongly discourages practice from having non-compete clause
apply to recruited physician; in these types of deals, recruiting institution usually subsidizes physicians income until revenue
rises to meet his or her needs; physician must then stay another 2 to 4 yr to get forgiveness of what institution classifies
as loan (this can have income tax consequences and should be reviewed by accountant before deal signed);
commentsunderstand any deal up front; read contract first, and outline questions before going to attorney or business
consultant; ask attorney or consultant how many deals they have done like yours
|
| Medical director agreements: internists best candidates for medical director positions; read agreement carefully before
signing; be careful of percentage-volume compensation; speaker offers scenario where institution offers physician
medical director position because it knows he or she is or could be good referral source; if agreement not structured properly,
it will violate federal antikickback statute (two-party statute; makes it criminal offense to knowingly and willfully
offer, pay, solicit, or receive any remuneration in exchange for referrals of items or services reimbursable by any federal
health care program; violation results in $25,000 minimum fine, minimum of 5 yr in prison, and mandatory exclusion
from Medicare and Medicaid); beware medical director agreements where you are referring physician; get everything in
writing; verbal contracts in Florida and most states are worthless and can lead to time-consuming and expensive depositions
|
| Call coverage agreements and arrangements: it is legal for hospitals to pay physicians to be on call in certain situations;
speaker recommends having written agreement; Office of Inspector General (OIG) has published advisory opinions
on how to properly structure these
|
| Joint venture agreements: highly suspect; speaker offers example of hospital with capital approaching doctor who is
referring physician for, eg, clinical laboratory tests or diagnostic imaging and proposing joint venture in diagnostic imaging
center; look at such deals carefully, possible violation of federal antikickback law
|
| Gainsharing agreements: gaining acceptance; financial arrangement between hospital and physician where hospital
gives physician percentage of savings generated by physicians cost reductions in medical management; at least ≥7 OIG
advisory opinions on gainsharing arrangements; these should be carefully reviewed before signed (if not done correctly,
could be violation of antikickback statute)
|
| Applicable laws: Florida Patient Self-Referral Act (§456.053, Florida Statutes); federal statutesStark Law (42
U.S.C. §1395nn) and Stark II regulations; Federal Anti-Kickback Statute (42 U.S.C. §1320a-7b[b]) and Safe Harbor
Regulations (42 C.F.R. §1001.952); laws highly complicated, and physician can be compliant with one and still be in
violation of another; Stark lawper se statute ie, intent to violate not required; applies only to physicians and to
Medicare or Medicaid patients; designed to prevent physicians from referring patients for ancillary service to entity
with which he or she has financial relationship; antikickback statuteintent-based statute; now 27 or 28 safe harbor
regulations; if physicians transaction meets the requirements for one of these, he or she is compliant; arrangements
that do not meet safe harbor regulations examined by OIG on case-by-case basis; antikickback statute applies to all
federally funded healthcare beneficiaries; Florida Patient Self-Referral and Patient Brokering Acts apply to all patient
referrals, including workers compensation, private insurance, self-pay, and indigent patients (many states have similar
statutes)
|
 | Comments: federal law applies across all 50 states; federal false claims act and tainted transaction theory
|
 | Purchase of physician practices: paramount consideration price paid for practice must be fair market value
(and speaker would argue that good will and trust generated by physician adds to that value)
|
Suggested Reading
Baker MM, Marinello ML: Playing nice. Noncompete terms in physician employment agreements. MGMA Connex 5:46,
2005; Blaszyk MD, Hill-Mischel J: Joint ventures: to pursue or not to pursue? Healthc Financ Manage 61:82, 2007;
Costello D: A checkup for retail medicine. Health Aff (Millwood) 27:1299, 2008; English J et al: Tread carefully. When
it comes to physician referrals, a few tips will help you avoid violating antikickback law. Mark Health Serv 27:26, 2007; Gass
A, Wilson J: Marketing off-label uses to physicians: FDA's draft (mis)guidance. Am J Bioeth 8:1, 2008; Johnson BA:
Clean dealing. Legal considerations for buy/sell agreements. MGMA Connex 2:38, 2002; Kahn CN 3rd : Caveat emptor: joint
ventures with specialty hospitals. Healthc Financ Manage 60:90, 2006; Kolar R: A consumer revolution in retail medicine:
where is it heading? Healthc Financ Manage 62:46, 2008; Lusis I, Hasselkus A: HIPAA privacy regulations. Semin
Speech Lang 27:89, 2006; Manchikanti L, McMahon EB: Physician refer thyself: is Stark II, phase III the final voyage?
Pain Physician 10:725, 2007; Mancino PB, Gulick SL: Protecting ownership of patient information. Behav Healthc
27:24, 2007; Medicare Rights Center: Off-base: limitations on Medicare Part D coverage of off-label prescriptions. Care
Manag J 9:142, 2008; No authors listed: OIG advisory opinion clarifies some call issues. ED Manag 19:128, 2007; Pearson
EZ: Paying your marketers--properly. Caring 22:18, 2003; Peltz S: Guidelines for corporate covenants and physician employment
agreements. J Med Pract Manage 19:146, 2003; Psaty BM, Ray W: FDA guidance on off-label promotion and the
state of the literature from sponsors. JAMA 299:1949, 2008; Regan J et al: Oversight and supervision of retail medical clinic
healthcare personnel. Tenn Med 101:39, 2008; Robeznieks A: Thumbs up and thumbs down? Contradictory opinion given on
gain-sharing deal. Mod Healthc 38:10, 2008; Rosenbaum S et al: Medicaid and health information: current and emerging legal
issues. Health Care Financ Rev 28:21, 2006; Sadan B: Patient data confidentiality and patient rights. Int J Med Inform
62:41, 2001; Sadick NS et al: Medical spa marketing. Dermatol Clin 26:391, 2008; Stafford RS: Regulating off-label
drug use--rethinking the role of the FDA. N Engl J Med 358:1427, 2008; Taub AF: Procedures offered in the medical spa environment.
Dermatol Clin 26:341, 2008; Threlkeld RC, Madison MP: Physicians... What to look for in contracts. J Med
Assoc Ga 96:27, 2007; Tinsley R: An inside look at recruitment agreements between hospitals and physicians. Tex Med 86:19,
1990; Torgerson PM: Gain-sharing with the hospital: what is possible in the current legal environment. Orthop Clin North
Am 39:33, 2008; Welch S: OIG considers pay-for-call arrangements. J Med Assoc Ga 97:47, 2008.
|